Taking Stock of CAR T-Cell Therapy
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
Progress Against Cancer
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
New studies probe how to match targeted therapies to children with cancer.
A magnet-guided robot could help doctors look for signs of cancer deeper in the passages of the lungs.
Study shows women have a higher risk of side effects from immunotherapy, adding to evidence that men and women react differently to treatment.
Genetic tests create opportunities but also confusion for breast cancer patients, and more from the week in cancer news.
Cognitive effects from COVID-19 and cancer treatment look very similar. Collaboration may lead to better treatment for both.
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
COVID-19 boosters promote immune response in additional blood cancer patients, and high drug costs lead cancer patients to not fill prescriptions.
People in treatment for early-stage cancer should try to get exercise, according to new recommendations.
Accounting for less than 1 percent of all newly diagnosed cancers in the United States each year, sarcomas are relatively rare. However, these cancers lead to death in approximately 35 percent of patients diagnosed...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 50,000 members worldwide drive progress against cancer.
Donate Now